Curative Biotechnology, Inc. (CUBT)
OTCMKTS: CUBT · Delayed Price · USD
0.0269
+0.0069 (34.50%)
May 2, 2024, 3:59 PM EDT - Market closed
Curative Biotechnology Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
16.92M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | - | - | - |
Dec 31, 2020 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCUBT News
- 4 weeks ago - Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors - GlobeNewsWire
- 6 months ago - Curative Biotechnology, Inc. Announces Nomination of Dr. Jeffrey Liebmann to Board of Directors - GlobeNewsWire
- 11 months ago - Curative Biotechnology Announces Establishment of Japanese Subsidiary for Licensing Transactions and Asset Acquisitions - GlobeNewsWire
- 1 year ago - Curative Biotechnology, Inc. Files Patent on Ophthalmic Formulation - GlobeNewsWire
- 1 year ago - Curative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study - GlobeNewsWire
- 1 year ago - Curative Biotechnology Announces Intent to Uplist to NYSE American Exchange - GlobeNewsWire
- 2 years ago - Curative Biotechnology Inc. Adds Biotech Veteran Lawrence S. Zaslow to Board of Directors - GlobeNewsWire
- 2 years ago - Curative Biotechnology, Inc. Names Cary Sucoff to Board of Directors - PRNewsWire